News

Filter

Current filters:

None

1 to 9 of 97876 results

Merck KGaA 4th-quarter 2014 earnings beat expectations

Merck KGaA 4th-quarter 2014 earnings beat expectations

03-03-2015

Germany’s Merck KGaA this morning reported financial results showing that group sales for the full…

FinancialMerck KGaAMerck SeronoPharmaceutical

NICE draft guidance backs Gilead’s Harvoni for treating chronic hepatitis C

NICE draft guidance backs Gilead’s Harvoni for treating chronic hepatitis C

03-03-2015

The National Institute for Health and Care Excellence (NICE), the medicines cost watchdog for England,…

Anti-viralsBiotechnologyGilead SciencesHarvoniPricingRegulationUK

Positive Ph III results for Portola’s Xarelto antidote andexanet alfa

02-03-2015

USA-based Portola Pharmaceuticals saw its shares jump 7.2% to $40.83 after it announced positive results…

andexanet alfaBayerBiotechnologyCardio-vascularPortola PharmaceuticalsRegulationResearchUSA

European Commission approves Actavis’ Xydalba

02-03-2015

The European Commission has granted Ireland-headquartered Actavis' subsidiary Durata Therapeutics International…

ActavisAngeliniAntibiotics and Infectious diseasesDalvanceDermatologicalsDurata TherapeuticsEuropePharmaceuticalXydalba

Boehringer Ingelheim files BLA with FDA for Pradaxa antidote idarucizumab

02-03-2015

German family-owned pharma major Boehringer Ingelheim has submitted a Biologics License Application (BLA)…

BiotechnologyBoehringer IngelheimCardio-vascularidarucizumabPradaxaRegulationUSA

1 to 9 of 97876 results

COMPANY SPOTLIGHT

Menarini

Back to top